The Impact of COVID-19 Lockdown on Health Behaviors among Students of a French University. 2021

Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
Clinical Investigation Center, CHU Rouen, U 1073, Normandie University, F 76000 Rouen, France.

This study aimed to determine the changes in health behaviors among students of a French university during the COVID-19 lockdown. An online retrospective survey was distributed to Rouen-Normandy University students at the end of the COVID-19 lockdown (13th March-11th May 2020). Voluntary university students were included. Data collected were on socio-demographics, academic environment, COVID19 concerns, tobacco smoking, binge drinking, cannabis use, and physical activity in the periods before and during COVID-19 lockdown. The survey was completed by 3671 university students (mean age 20.9 ± 2.47 years, 72.9% female). Significantly favorable changes between the periods before and during COVID-19 were reported for tobacco smoking (18.5% vs. 14.8%), binge drinking (35.9% vs. 9.3%) and cannabis use (5.6% vs. 3.2%) and unfavorable changes for moderate (79.4% vs. 67.9%) and vigorous physical activity (62.5% vs. 59.1%). After logistic regression, factors associated with unfavorable changes in tobacco smoking and with favorable changes in vigorous physical activity were the worry of not validating the academic year and stress related to changes in the mode of teaching, respectively. For each health behavior, unfavorable changes were associated with higher depression levels, and male gender. Then as a decrease, mainly in binge drinking was observed during the COVID-19 lockdown, care must be taken to prevent university students from resuming binge drinking after the end of the lockdown. Health-promotion strategies directed at adopting or maintaining positive mental health and promoting physical activity should be developed for university students to better manage future lockdown periods.

UI MeSH Term Description Entries
D008297 Male Males
D003140 Communicable Disease Control Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man. Flatten the Curve of Epidemic,Flattening the Curve, Communicable Disease Control,Parasite Control,Control, Communicable Disease,Control, Parasite
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013334 Students Individuals enrolled in a school or formal educational program. School Enrollment,Enrollment, School,Enrollments, School,School Enrollments,Student

Related Publications

Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
January 2022, Frontiers in psychology,
Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
November 2022, International journal of environmental research and public health,
Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
November 2021, Scientific reports,
Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
January 2021, Frontiers in sports and active living,
Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
November 2020, Global challenges (Hoboken, NJ),
Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
September 2021, Medwave,
Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
February 2024, L'Encephale,
Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
March 2021, Journal of affective disorders,
Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
April 2023, Journal of American college health : J of ACH,
Marie Pierre Tavolacci, and Edwin Wouters, and Sarah Van de Velde, and Veerle Buffel, and Pierre Déchelotte, and Guido Van Hal, and Joel Ladner
January 2021, Journal of neurology,
Copied contents to your clipboard!